Research programme: CRH analogues - Neurobiological/University of California
Alternative Names: Corticotropin releasing hormone analogues research programmeLatest Information Update: 12 Dec 2003
Price :
$50 *
At a glance
- Originator University of California at Berkeley
- Developer Neurobiological Technologies
- Class
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 31 Jul 2003 Discontinued - Preclinical for Cancer in USA (unspecified route)
- 17 Aug 2000 Preclinical development for Cancer in USA (Unknown route)